Pelthos Therapeutics Inc.
New Filing
CIK: 0001919246·Pharmaceuticals·NEVADA·Filed: Jul 10, 2025
Total Offering
$50,100,000
Amount Sold
$50,100,000
Investors
13
First Sale
Jul 1, 2025
Offering Details
- Type
- Equity, Option to Acquire, Security to be Acquired, Other: Series A Convertible Preferred Stock, par value $0.0001 per share, convertible into shares of the Company's common stock, par value $0.0001 per share.
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2021
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Francis Knuettel II | Related Person |
| Richard Malamut | Related Person |
| Scott Plesha | Related Person |
| Richard Baxter | Related Person |
| Sai Rangarao | Related Person |
| Ezra Friedberg | Related Person |
| Todd Davis | Related Person |
| Peter Greenleaf | Related Person |
| Matthew Pauls | Related Person |
Company
SEC Filing
0001753926-25-001126
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free